Patent classifications
C08B31/08
Method for preparation of polysaccharide-based emulsion for binding and coating applications
According to an example aspect of the present invention, here is provided a polysaccharide ether grafted with poly(alkyl acrylate), a latex comprising a polysaccharide ether grafted with poly(alkyl acrylate), and a method of manufacturing a biobased emulsion comprising the steps of providing an allylated polysaccharide ether derivative and grafting the allylated polysaccharide ether derivative with a poly(alkyl acrylate) by emulsion polymerization, a biobased film formed by the said latex or said method and the use of the latex and emulsion.
Method for preparation of polysaccharide-based emulsion for binding and coating applications
According to an example aspect of the present invention, here is provided a polysaccharide ether grafted with poly(alkyl acrylate), a latex comprising a polysaccharide ether grafted with poly(alkyl acrylate), and a method of manufacturing a biobased emulsion comprising the steps of providing an allylated polysaccharide ether derivative and grafting the allylated polysaccharide ether derivative with a poly(alkyl acrylate) by emulsion polymerization, a biobased film formed by the said latex or said method and the use of the latex and emulsion.
MODIFIED STARCH MATERIAL OF BIOCOMPATIBLE HEMOSTASIS
A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.
Process for making a modified starch product
A process for modifying starch is described. The process can be used as an alternative to conventional starch modification processes, such as substitution and crosslinking. The process and resulting product can reduce, substantially reduce, substantially eliminate or eliminate the sodium level typically associated with conventionally modified starch products.
Modified starch material of biocompatible hemostasis
A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.
Modified starch material of biocompatible hemostasis
A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal.